Study creates blood vessel cells from stem cells (1/25/2010)
New York Stem Cell Foundation (NYSCF)-Druckenmiller Fellow, Daylon James, PhD, of Weill Cornell Medial College, is lead author on a study defining conditions for generating a plentiful supply of endothelial (vessel lining) cells that are suitable for therapeutic use. Dr. James and his colleagues created a human embryonic stem cell (hESC) "reporter" line that can be used to measure endothelial cell production and activity.
The study, Expansion and maintenance of human embryonic stem cell-derived endothelial cells by TGFβ inhibition is Id1 dependent, was published in the online edition of Nature Biotechnology on January 17th, 2010, and will also appear in the journal's print edition. In addition to Dr. James, whose work is funded by NYSCF, contributors to the study also included NYSCF-Druckenmiller Fellows, Drs. Gabsang Lee and Marco Seandel.
Using the reporter line, Dr. James and his colleagues were able to monitor the emergence of endothelial cells in live cultures, and screen for small bioactive molecules that increased their yield. By this method, they were able to indentify a compound that robustly increased the amount of endothelial cells produced. This work establishes a standard methodology for generating functional endothelial cells from hESCs using conditions that are suited to clinical application. These cells can now be routinely and economically produced on scales that make pre-clinical assessment of their efficacy practical in large animal models of vascular disease.
"We are very proud of Dr. James. These findings bring us closer to having functional endothelial cells available for studying vascular disease," says Susan L. Solomon, NYSCF's founder and CEO.
As advancements in induced pluripotent stem (iPS) cell technology continue, hESC research like that of Dr. James is essential for the field of stem cell research. Embryonic stem cells are still the gold standard for monitoring pluripotency and differentiation capabilities.
"It is research like this that brings us closer to cures for the major diseases of our time," said Dr. Kevin Eggan, Chief Scientific Officer of NYSCF. "Daylon is one of the premier young scientists in the field of stem cell research and we are excited to have him in our fellowship program."
Note: This story has been adapted from a news release issued by the New York Stem Cell Foundation
Post Comments:
| 
Subscribe
Scientists discover 'catastrophic event' behind the halt of star birth in early galaxy formation
Fish can recognize a face based on UV pattern alone
Ancient DNA from rare fossil reveals that polar bears evolved recently and adapted quickly
'Anaconda' meets 'Jurassic Park': Study shows ancient snakes ate dinosaur babies
Scientists locate apparent hydrothermal vents off Antarctica
Artificial bee silk a big step closer to reality
Artificial foot recycles energy for easier walking
New fiber nanogenerators could lead to electric clothing
What drives our genes? Researchers map the first complete human epigenome
Juggling enhances connections in the brain
Tracking down the human 'odorprint'
Fill 'er up - with algae
Scientists discover quantum fingerprints of chaos
Researchers help identify cows that gain more while eating less
Chemists influence stem-cell development with geometry
Sonic hedgehog gene found in an unexpected place during limb development
Chemical competition: Research identifies new mechanism regulating embryonic development
Mathematical innovation turns blood draw into information gold mine in Stanford study
Deceptive model